Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CAN (ON): Kincardine-based cultivation facility receives EU-GMP

Canopy Growth received EU GMP certification from RP Tuebingen, Regional Health Inspectorate of Baden-Wuerttemberg, for the Company’s world-class cannabis cultivation facility in Kincardine, Ontario.

As a final step to completing the Company’s consolidation of its production footprint into two purpose-built sites, the receipt of EU GMP certification enables Canopy Growth to continue exporting certified medical cannabis to medical markets in Europe as well as other medical cannabis markets around the world.

“The receipt of EU GMP certification for our Kincardine facility is a significant milestone for Canopy Growth as we complete the transformation of our business and position it for long-term growth and market leadership,” said David Klein, Chief Executive Officer of Canopy Growth. “Today’s announcement further demonstrates our team’s proven ability to evolve our business and positions us to continue serving medical cannabis customers in Europe and around the world with high-quality flower.”

For more information:
Canopy Growth
www.canopygrowth.com

Publication date: